This thought paper by VISION-DMD, supported by an Expert Advisory Panel, offers a summary of the current challenges and knowledge gaps in the use of robust biomarkers for optimizing clinical trial outcomes. It highlights the urgent need for a central and coordinated approach to support their identification, adoption and qualification to accelerate future research breakthroughs for DMD.
